Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
SCL · 10-Q filed May 6, 2026

SCL earnings analysis

What we found in SCL's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Stepan Company reported Q1 2026 revenues of $604.5 million, slightly below estimates of $615.9 million, while adjusted EPS of $0.45 exceeded the consensus estimate of $0.35. The company faced a significant restructuring charge of $65.4 million that contributed to a net loss of $41.4 million for the quarter, but organic sales increased 4% year-over-year.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Adjusted EPS Beats Estimates
Adjusted EPS was $0.45, surpassing the estimate of $0.35.
Revenue Growth Despite Miss
Revenues increased by $11.2 million YoY to $604.5 million.
Positive Operating Cash Flow
Operating cash flow improved to $16.9 million, up from $6.9 million YoY.
Segment Growth in Specialty Products
Specialty Products revenue grew 24% year-over-year.
Cash Increase
Cash and cash equivalents rose by $8.1 million to $140.8 million.
Higher Selling Prices Impact Revenue
Sales benefited from a $25.3 million favorable foreign currency translation.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Significant Restructuring Costs
The company recognized a $65.4 million pre-tax business restructuring charge.
Net Loss Increased
Net loss was $41.4 million versus a profit of $19.7 million in 2025 Q1.
Debt Levels Increased
Debt rose by $25 million to $651.7 million on March 31, 2026, from $626.7 million.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$0.45
Segment
Surfactants
Segment
Polymers
Segment
Specialty Products
Guidance

What they said about what is next.

The Company maintains positive guidance for full-year adjusted EBITDA growth and expects to achieve positive free cash flow.

How we read the filing overall

The filing reads about the same as the one before it.

One reading of one document. It is not advice, and it is not a forecast.

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing SCL makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever